If you were going to put together a program on whole slide imaging for clinical validation, second opinion consultations, primary diagnosis and using the technology in conjunction with clinical trials you would have part of the Second Annual Digital Pathology educational sessions at the upcoming Molecular Medicine Tri-Conference in San Francisco in early February.  The entire program for the digital pathology conference was mentioned in a previous post highlighted with a talk by Dr. George Lundberg on how molecular pathology blends with laboratory medicine. This is a high quality program at reasonable cost. Check out the entire conference offerings here.

Digital Pathology | February 10-12  | San Francisco, CA

Second Annual
Digital Pathology
Transforming Medicine in a Digital World
February 10-12, 2014 | San Francisco, CA


Join more than 3,000 informatics, clinical, diagnostics, and oncology researchers at the 21st Molecular Medicine Tri-Conference!



Cambridge Healthtech Institute’s Second Annual Digital Pathology Conference will have a special focus on the application of whole-slide images including the three below presentations on February 12. The final opportunity to take advantage of registration discounts up to $200 is this Friday, January 17.

Implementing WSI in a Large Academic Hospital
Thomas W. Bauer, M.D., Ph.D., Medical Director, ePathology, Cleveland Clinic
Thomas BauerSuccessful implementation of WSI for research, education, and patient care in a large academic department requires acceptance among more than just early adopters. This talk will review the Cleveland Clinic’s strategy to develop, implement and measure a dynamic “digital education library”, and the outcome of the secondary diagnosis validation study.

Thomas W. Bauer, MD, PhD, specializes in orthopaedic and gastrointestinal pathology. He holds joint appointments in the Institutes of Orthopaedics and Rheumatology as well as Spine, and his research interests involve mostly orthopaedic biomaterials. Dr. Bauer is board-certified in Anatomic and Clinical Pathology and joined the staff of Cleveland Clinic in 1983. His research laboratory investigates the development of new materials and designs in spine and skeletal reconstruction, cartilage repair and total joint arthroplasty, and he is considered an expert in the mechanisms of success and failure of orthopaedic devices. He has given more than 150 invited lectures, and has served as a consultant and voting member to U.S. Food and Drug Administration advisory panels in two different divisions. He has published more than 225 manuscripts and book chapters and is also Deputy Editor for Research for The Journal of Bone and Joint Surgery.

Use of Whole Slide Imaging for Primary Diagnosis in Canada
Andrew J. Evans, M.D., Ph.D., FRCPC, Staff Pathologist & Associate Professor, University Health Network, Laboratory Medicine Program
Andrew Evans
There is growing acceptance for using WSI for diagnostic purposes, including consultations and frozen sections. Interest in Canada and other countries is also building around the use of this technology for primary diagnosis, particularly in multi-site institutions with consolidated pathology departments and subspecialty sign out. This presentation will review logistical, regulatory and medicolegal factors that facilitate the use of WSI for primary diagnosis in these situations in Canada.

Dr. Evans is a Staff Pathologist and consultant in urological pathology at University Health Network (UHN) in Toronto, Ontario, Canada.  He is also an Associate Professor in the Department of Laboratory Medicine and Pathobiology at The University of Toronto.  He has served as Director of the UHN Telepathology program since its inception in 2003.  UHN has successfully integrated digital pathology into patient care for a variety of applications, including frozen sections,  consultation and primary sign out.

Implementation of WSI for Consensus Review in Clinical Trials
Stephen M. Hewitt, M.D., Ph.D., Clinical Investigator, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute
Stephen HewittThe implementation of whole-slide imaging in a clinical trial setting offers a critical view of the challenges in implementation of the technology into the pathology routine. This presentation will discuss the advantages of the adoption of WSI in a clinical trial, as well as the considerations and technical task of implementation for a successful integration of digital pathology in clinical trials.

Dr. Hewitt is a clinical investigator in the Laboratory of Pathology, National Cancer Institute. His research interests include tissue-based biomarkers, high-throughput pathology, and whole-slide imaging.  Dr. Hewitt is a councilor of the Histochemical Society, Program Committee Chair-elect for the Association for Pathology Informatics and a consultant to the Hematology and Pathology Devices Panel, Center for Devices and Radiological Health, Food and Drug Administration. Dr Hewitt has co-authored over 200 articles and serves on the editorial board of four peer-reviewed journals.

Learn More   |   View Brochure   |   Register  (Savings Up to $200 Available Until January 17)


Save up to $1,500 with an All Access Package
Suggested All Access Package includes two short courses, 
Latest Advances in Molecular Pathology and Next-Generation Sequencing in Molecular Pathology: Challenges and Applications, the Genomics in Medicine symposium, plus the Digital Pathology conference track. These two short courses are co-organized with the College of American Pathology 
CAP  

See more

OR

Comments (1)

platinum partners

gold partners

Silver Partners

Media Partners